Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Galloway Jones Consulting

Galloway Jones Consulting Ltd was founded in 2007 by Alan Jones. Alan is able to offer more than ten years’ experience recruiting for the Pharmaceutical Industry in both the UK and Europe. This knowledge allows him to create a bespoke recruitment service for client and candidate alike. GJC recruit in all areas of the Pharmaceutical industry; including, but not limited to: Public Relations, Medical Communications, Medical Writing, Marketing, Market Research, Health Economics, Sales and Business Development and Medical Affairs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Galloway Jones Consulting
The Atrium, Curtis Road, Dorking, Surrey, RH4 1XA, United Kingdom
+44 (0)1306 64 68 91
Contact Galloway Jones Consulting
Website

 Latest Content from PMHub 

Enhancing Focus in Virtual Meetings: Stick to a Theme – Impetus InSite Tips #5

Videos and Podcasts | April 25, 2024 | Impetus Digital

Focus your virtual meetings with a clear theme! Tip 5 from our ImpetusInSite Tips series shows how sticking to one theme per touchpoint can dramatically improve engagement and coherence. Learn...

Showing Deep Expertise at ONS

Press Releases | April 24, 2024 | Medscape Education

The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024.  Medscape Oncology has deep expertise in the oncology...

MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME

Press Releases | April 24, 2024 | Medscape Education

The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for...

Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

White Papers and Resources | April 24, 2024 | Inizio

This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

Rebrand for Cheshire creative agency, LOVELIVE

Press Releases | April 24, 2024 | LOVELIVE

Cheshire creative agency LOVELIVE has unveiled a new-look branding; coinciding with the launch of a new website as they celebrate 22% year on year growth and an exciting new focus.

Fox&Cat Relaunches With An Industry-First Efficiency & Effectiveness Planning Framework, ADAPTTM

Press Releases | April 24, 2024 | Fox&Cat

F&C network team picture, March 2024 Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPTTM. The agency’s lean model...

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

White Papers and Resources | April 22, 2024 | Inizio

Authored by: Ellie Forde and Mark Braund, Directors

Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4

Videos and Podcasts | April 18, 2024 | Impetus Digital

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...

Navigating Stress: Understanding, Addressing, and Supporting Our Team

White Papers and Resources | April 17, 2024 | Mednet

Explore how we're supporting our team with managing stress in the workplace

Research conducted for Johnson and Johnson published in scientific journal

Press Releases | April 17, 2024 | Inizio

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.